Search Results | Blood | American Society of Hematology

1-20 of 32

Sort by

Sort Order Select

Journal Articles

Modified Risk-Stratified Sequential Treatment in B-Cell Post-Transplant Lymphoproliferative Disorder (PTLD) after Solid Organ Transplantation (SOT): The Prospective Multicenter Phase II PTLD-2 Trial

Heiner Zimmermann, Christian Koenecke, Martin H. Dreyling, Christiane Pott, Ulrich Dührsen, Dennis Hahn, Norbert Meidenbauer, Ingeborg A Hauser, Mathias J. Rummel, Dominik Wolf, Michael Heuser, Christian Schmidt, Peter Schlattmann, Matthias Ritgen, Reiner Siebert, Ilske Oschlies, Ioannis Anagnostopoulos, Ralf Ulrich Trappe

Blood (2021) 138 (Supplement 1): 3555.

DOI: https://doi.org/10.1182/blood-2021-146823

Published: 2021

Journal Articles

Continuous Clinical Remisssion with High MRD Negativity and High PB and BM MRD Concordance during Venetoclax Monotherapy in R/R CLL Patients

Maria Dimou, MD PhD, Ioannis Anagnostopoulos, MD, Sotiria Kalyva, PhD, Vasileios Pardalis, MD, Athanasios Markopoulos, PhD, Aikaterini Bitsasni, MD, Theodoros Iliakis, MD, Marie-Christine Kyrtsonis, MD, Panayiotis Panayiotidis, MD

Blood (2020) 136 (Supplement 1): 1.

DOI: https://doi.org/10.1182/blood-2020-142992

Published: 2020

Journal Articles

AML: Negative Prognostic Impact of Early Blast Persistence Can be Overcome By Subsequent Remission Induction

Jana Ihlow, MD, Sophia Gross, Leonie Busack, Alma Herneth, Igor-Wolfgang Blau, MD PhD, Ioannis Anagnostopoulos, MD, Michaela Schwarz, MD, Anne Floercken, MD, Lars Bullinger, MD, Jörg Westermann, MD

Blood (2019) 134 (Supplement_1): 1324.

DOI: https://doi.org/10.1182/blood-2019-127174

Published: 2019

Journal Articles

B-cell receptor–driven MALT1 activity regulates MYC signaling in mantle cell lymphoma

Blood (2017) 129 (3): 333–346.

DOI: https://doi.org/10.1182/blood-2016-05-718775

Published: 2017

Includes: Supplemental data

Journal Articles

B-Cell Receptor Driven MALT1 Activity Regulates MYC Signaling in Mantle Cell Lymphoma

Blood (2016) 128 (22): 611.

DOI: https://doi.org/10.1182/blood.V128.22.611.611

Published: 2016

Journal Articles

Essential role of IRF4 and MYC signaling for survival of anaplastic large cell lymphoma

Blood (2015) 125 (1): 124–132.

DOI: https://doi.org/10.1182/blood-2014-08-594507

Published: 2015

Includes: Supplemental data

Journal Articles

Bone marrow T-cell infiltration during acute GVHD is associated with delayed B-cell recovery and function after HSCT

Angela Mensen, Korinna Jöhrens, Ioannis Anagnostopoulos, Sonya Demski, Maike Oey, Andrea Stroux, Philipp Hemmati, Jörg Westermann, Olga Blau, Friedrich Wittenbecher, Kamran Movassaghi, Martin Szyska, Sybill Thomas, Bernd Dörken, Carmen Scheibenbogen, Renate Arnold, Il-Kang Na

Blood (2014) 124 (6): 963–972.

DOI: https://doi.org/10.1182/blood-2013-11-539031

Published: 2014

Includes: Supplemental data

Journal Articles

Acute Bone Marrow GvHD Is Associated With Delayed B Cell Neogenesis and Impaired Natural Antibody Response After Allogeneic Hematopoietic Stem Cell Transplantation

Angela Mensen, Korinna Jöhrens, Ioannis Anagnostopoulos, Sonya Demski, Christoph Ochs, Philipp Hemmati, MD, Giang Lam Vuong, MD, Kathrin Rieger, Olga Blau, Jörg Westermann, MD, Bernd Dörken, Carmen Scheibenbogen, Renate Arnold, Il-Kang Na

Blood (2013) 122 (21): 4605.

DOI: https://doi.org/10.1182/blood.V122.21.4605.4605

Published: 2013

Journal Articles

BRAFV600E mutant protein is expressed in cells of variable maturation in Langerhans cell histiocytosis

Felix Sahm, David Capper, Matthias Preusser, Jochen Meyer, Albrecht Stenzinger, Felix Lasitschka, Anna-Sophie Berghoff, Antje Habel, Marion Schneider, Andreas Kulozik, Ioannis Anagnostopoulos, Leonhard Müllauer, Gunhild Mechtersheimer, Andreas von Deimling

Blood (2012) 120 (12): e28–e34.

DOI: https://doi.org/10.1182/blood-2012-06-429597

Published: 2012

Includes: Supplemental data

Journal Articles

Sequential Treatment with Rituximab Followed by CHOP Chemotherapy in Adult B-Cell Post-Transplant Lymphoproliferative Disorder (PTLD) - Establishing a New Standard of Care: Final Results From the Prospective International Multicenter PTLD-1 Trial

Ralf Trappe, MD, PhD, Stephan H.K. Oertel, MD, Veronique Leblond, MD, PhD, Peter Mollee, MBBS, MMedSc, Monica Sender, MD, Petra Reinke, MD, PhD, Ruth Neuhaus, MD, Hans Lehmkuhl, MD, PhD, Heinz A. Horst, MD, Gilles Andre Salles, MD, PhD, Franck Morschhauser, Arnaud Jaccard, MD, PhD, Thierry Lamy, MD, PhD, Malte Leithäuser, MD, Ioannis Anagnostopoulos, MD, PhD, Martine Raphael, MD, PhD, Hanno Riess, MD, PhD, Sylvain Choquet, MD

Blood (2011) 118 (21): 878.

DOI: https://doi.org/10.1182/blood.V118.21.878.878

Published: 2011

Journal Articles

High-Level Expression of Mastermind-Like 2 (MAML2) Contributes to Aberrant Activation of the NOTCH Signaling Pathway In Human Lymphomas

Karl Köchert, Stephan Kreher, Jon C Aster, MD, PhD, Motoo Kitagawa, Korinna Jöhrens, Ioannis Anagnostopoulos, Franziska Jundt, MD, PD, Harald Stein, MD, Martin Janz, MD, Bernd Dörken, MD, Stephan Mathas, MD

Blood (2010) 116 (21): 2685.

DOI: https://doi.org/10.1182/blood.V116.21.2685.2685

Published: 2010

Journal Articles

Sequential Treatment with Rituximab and CHOP Chemotherapy in B-Cell PTLD - Moving Forward to a First Standard of Care: Results From a Prospective International Multicenter Trial.

Blood (2009) 114 (22): 100.

DOI: https://doi.org/10.1182/blood.V114.22.100.100

Published: 2009

Journal Articles

C/EBPβ regulates transcription factors critical for proliferation and survival of multiple myeloma cells

Rekha Pal, Martin Janz, Deborah L. Galson, Margarete Gries, Shirong Li, Korinna Jöhrens, Ioannis Anagnostopoulos, Bernd Dörken, Markus Y. Mapara, Lisa Borghesi, Lela Kardava, G. David Roodman, Christine Milcarek, Suzanne Lentzsch

Blood (2009) 114 (18): 3890–3898.

DOI: https://doi.org/10.1182/blood-2009-01-201111

Published: 2009

Includes: Supplemental data

Journal Articles

Reduction of Immunosuppression and Subsequent Rituximab Monotherapy or CHOP-Based Chemotherapy +/− Rituximab as a Treatment for PTLD Does No Impair the Renal Graft Function: A Matched Pair Control Analysis in 55 Renal Transplant Recipients with PTLD and 1075 Renal Transplant Controls

Ulrike Appel, Carl Hinrichs, Petra Reinke, Nina Babel, Hans H Neumayer, Klemens Budde, Martin Dreyling, Ulrich Dührsen, Volker Kliem, Silke Schüttrumpf, Ingeborg A Hauser, Hans G Mergenthaler, Bernd Dörken, Ioannis Anagnostopoulos, Hanno Riess, Ralf Trappe, On behalf of the German Study Group on PTLD

Blood (2008) 112 (11): 3613.

DOI: https://doi.org/10.1182/blood.V112.11.3613.3613

Published: 2008

Journal Articles

Results of the Largest Study on Post-Transplant-Lymphoproliferations (PTLDs) of the Central Nervous System (CNS) in the Rituximab Era: A Surprising Overrepresentation of Kidney Transplantations, Key Importance of Methotrexate (Mtx), Cytarabine (AraC) and Radiotherapy (RX) for Long Term Survival and Low Impact of Rituximab (R)

Sylvain Choquet, Stefan Oertel, Ioannis Anagnostopoulos, Hanno Riess, Madalina Uzunov, V.éronique Leblond, Ralf Trappe

Blood (2008) 112 (11): 3614.

DOI: https://doi.org/10.1182/blood.V112.11.3614.3614

Published: 2008

Journal Articles

Aberrant expression of the Th2 cytokine IL-21 in Hodgkin lymphoma cells regulates STAT3 signaling and attracts T reg cells via regulation of MIP-3α

Björn Lamprecht, Stephan Kreher, Ioannis Anagnostopoulos, Korinna Jöhrens, Giovanni Monteleone, Franziska Jundt, Harald Stein, Martin Janz, Bernd Dörken, Stephan Mathas

Blood (2008) 112 (8): 3339–3347.

DOI: https://doi.org/10.1182/blood-2008-01-134783

Published: 2008

Includes: Supplemental data

Journal Articles

Influence of antigen on the development of MALT lymphoma

Dido Lenze, Erika Berg, Rudolf Volkmer-Engert, Armin A. Weiser, Axel Greiner, Constanze Knörr-Wittmann, Ioannis Anagnostopoulos, Harald Stein, Michael Hummel

Blood (2006) 107 (3): 1141–1148.

DOI: https://doi.org/10.1182/blood-2005-04-1722

Published: 2006

Journal Articles

Elevated NF-κB p50 complex formation and Bcl-3 expression in classical Hodgkin, anaplastic large-cell, and other peripheral T-cell lymphomas

Stephan Mathas, Korinna Jöhrens, Stefan Joos, Andreas Lietz, Franziska Hummel, Martin Janz, Franziska Jundt, Ioannis Anagnostopoulos, Kurt Bommert, Peter Lichter, Harald Stein, Claus Scheidereit, Bernd Dörken

Blood (2005) 106 (13): 4287–4293.

DOI: https://doi.org/10.1182/blood-2004-09-3620

Published: 2005

Journal Articles

Jagged1-induced Notch signaling drives proliferation of multiple myeloma cells

Franziska Jundt, Kristina Schulze Pröbsting, Ioannis Anagnostopoulos, Gwendolin Muehlinghaus, Manik Chatterjee, Stephan Mathas, Ralf C. Bargou, Rudolf Manz, Harald Stein, Bernd Dörken

Blood (2004) 103 (9): 3511–3515.

DOI: https://doi.org/10.1182/blood-2003-07-2254

Published: 2004

Journal Articles

Epstein-Barr virus infection in Western European pediatric non-Hodgkin lymphomas

Matthias A. Karajannis, Michael Hummel, Ilske Oschlies, Ioannis Anagnostopoulos, Martin Zimmermann, Harald Stein, Reza Parwaresch, Alfred Reiter

Blood (2003) 102 (12): 4244.

DOI: https://doi.org/10.1182/blood-2003-08-2986

Published: 2003

NARROW

Modified Risk-Stratified Sequential Treatment in B-Cell Post-Transplant Lymphoproliferative Disorder (PTLD) after Solid Organ Transplantation (SOT): The Prospective Multicenter Phase II PTLD-2 Trial

Continuous Clinical Remisssion with High MRD Negativity and High PB and BM MRD Concordance during Venetoclax Monotherapy in R/R CLL Patients

AML: Negative Prognostic Impact of Early Blast Persistence Can be Overcome By Subsequent Remission Induction

B-cell receptor–driven MALT1 activity regulates MYC signaling in mantle cell lymphoma

B-Cell Receptor Driven MALT1 Activity Regulates MYC Signaling in Mantle Cell Lymphoma

Essential role of IRF4 and MYC signaling for survival of anaplastic large cell lymphoma

Bone marrow T-cell infiltration during acute GVHD is associated with delayed B-cell recovery and function after HSCT

Acute Bone Marrow GvHD Is Associated With Delayed B Cell Neogenesis and Impaired Natural Antibody Response After Allogeneic Hematopoietic Stem Cell Transplantation

BRAFV600E mutant protein is expressed in cells of variable maturation in Langerhans cell histiocytosis

Sequential Treatment with Rituximab Followed by CHOP Chemotherapy in Adult B-Cell Post-Transplant Lymphoproliferative Disorder (PTLD) - Establishing a New Standard of Care: Final Results From the Prospective International Multicenter PTLD-1 Trial

High-Level Expression of Mastermind-Like 2 (MAML2) Contributes to Aberrant Activation of the NOTCH Signaling Pathway In Human Lymphomas

Sequential Treatment with Rituximab and CHOP Chemotherapy in B-Cell PTLD - Moving Forward to a First Standard of Care: Results From a Prospective International Multicenter Trial.

C/EBPβ regulates transcription factors critical for proliferation and survival of multiple myeloma cells

Reduction of Immunosuppression and Subsequent Rituximab Monotherapy or CHOP-Based Chemotherapy +/− Rituximab as a Treatment for PTLD Does No Impair the Renal Graft Function: A Matched Pair Control Analysis in 55 Renal Transplant Recipients with PTLD and 1075 Renal Transplant Controls

Aberrant expression of the Th2 cytokine IL-21 in Hodgkin lymphoma cells regulates STAT3 signaling and attracts T reg cells via regulation of MIP-3α

Influence of antigen on the development of MALT lymphoma

Elevated NF-κB p50 complex formation and Bcl-3 expression in classical Hodgkin, anaplastic large-cell, and other peripheral T-cell lymphomas

Jagged1-induced Notch signaling drives proliferation of multiple myeloma cells

Epstein-Barr virus infection in Western European pediatric non-Hodgkin lymphomas

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only